“For critical cases only” … France is the first in treating Corona patients with chloroquine

On Monday, the Supreme Council of Health in France allowed all hospitals to use the “chloroquine” medicine intended for malaria to treat people infected with the Coronavirus before the end of ongoing clinical tests, according to the Al Hurra correspondent in Paris.

The drug is required to be used only for critical cases, as French Health Minister Olivier Ferrand, in an interview with reporters, said Monday that “the Supreme Council recommends that the drug be used excluding critical cases and those cases referred to hospitals according to a decision reached by doctors and under strict medical supervision.”

The United States was one of the first countries to highlight the use of the drug to treat the emerging coronavirus that causes Covid-19, as US President Donald Trump on Thursday confirmed the US Food and Drug Administration’s FDA approval of the hydroxychloroquine trial. Anti-malarial, to treat the emerging corona virus.

One of the drugs on the list, chloroquine, which the US administration recently announced, is already killing the single-celled parasites responsible for malaria. Scientists have learned that the drug can communicate with human proteins, especially the sigma-1 protein, which is targeted by the emerging virus, and is still Undergoes many experiments.

And New York City announced a test for chloroquine and hydroxychloroquine, and an antibiotic called azithromycin to study its effect on the emerging virus.

These vaccines are part of a global study of a wide range of medications, including drugs intended to treat AIDS and antiviral symptoms.

Of course, chloroquine, which the US administration recently announced, is one of the drugs on the list, and it already kills the single-celled parasites responsible for malaria, and scientists have learned that the drug can interact with human proteins, especially the “sigma-1” protein, which is targeted by the emerging virus, nor Still undergoing many experiments.

–

– .